Filing Details

Accession Number:
0000899243-22-004782
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-04 08:30:10
Reporting Period:
2022-02-02
Accepted Time:
2022-02-04 08:30:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1847903 Centessa Pharmaceuticals Plc CNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861926 Saurabh Saha C/O Centessa Pharmaceuticals Plc
3Rd Fl., 1 Ashley Rd, Altrincham
Cheshire X0 WA14 2DT
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2022-02-02 5,000 $9.74 28,000 No 4 P Indirect By trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trust
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.65 to $9.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  3. These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.